Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06680700 · ClinicalTrials.gov registry record

Controlled Desaturation Study for Perin Health Patch Validation

A clinical trial of Oxygen Saturation Measurement, sponsored by Perin Health Devices.

Recruiting
Registry status
25
Enrollment target
1
Study location

NCT06680700: Recruiting study of Oxygen Saturation Measurement, sponsored by Perin Health Devices.

NCT06680700 is a study of Oxygen Saturation Measurement that is actively recruiting participants, run by Perin Health Devices. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06680700, a study of Oxygen Saturation Measurement, is actively recruiting participants, sponsored by Perin Health Devices.

RECRUITING
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the accuracy of the Perin Health Patch (PHP), a non-invasive, chest-worn device that measures blood oxygen levels, by comparing its readings to a standard pulse oximeter device. The PHP device uses light sensors to measure blood oxygen saturation (SpO2), similar to how standard pulse oximeters work, and could allow for continuous remote monitoring at home. Participants in this study will breathe low-oxygen air through a mask to simulate different oxygen levels in a controlled environment. The goal is to see if the PHP device can accurately measure blood oxygen levels under different conditions and meet safety standards set by the FDA and international guidelines.

Primary Outcome

The primary outcome measure is the accuracy of blood oxygen saturation (SpO2) readings from the Perin Health Patch (PHP) in comparison to those from a reference pulse oximeter. Accuracy will be determined by calculating the mean difference (bias) and standard deviation of differences (precision) between the SpO2 measurements obtained from the PHP and those from the reference devices across a range of hypoxemic conditions (70-100% SpO2). The PHP's SpO2 accuracy will be assessed using a root-mean

Interventions

  • DEVICE Perin Health Patch

Study Locations (1)

California

  • Perin Health Devices - Woodland Hills

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-10-21
Est. Completion 2025-03-31
Perin Health Devices

5 total trials

What NCT06680700 shows while recruiting

NCT06680700 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.

The record links to 1 condition, with Oxygen Saturation Measurement appearing as the primary indexed condition, and to 1 intervention - of which Perin Health Patch is the first listed.

NCT06680700 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06680700 about?

NCT06680700 is a clinical study titled "Controlled Desaturation Study for Perin Health Patch Validation". This study aims to test the accuracy of the Perin Health Patch (PHP), a non-invasive, chest-worn device that measures blood oxygen levels, by comparing its readings to a standard pulse oximeter device. The PHP device uses light sensors to measure blood oxygen saturation (SpO2), similar to how standa...

What is the current status of trial NCT06680700?

This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2024-10-21. Estimated completion is 2025-03-31.

What conditions does trial NCT06680700 study?

This clinical trial studies the following conditions: Oxygen Saturation Measurement.

What interventions are being tested in trial NCT06680700?

The interventions under investigation include: Perin Health Patch (DEVICE).

Who is sponsoring clinical trial NCT06680700?

This trial is sponsored by Perin Health Devices, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06680700 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oxygen Saturation Measurement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06680700, the US trial registry maintained by the National Library of Medicine. NCT06680700 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.